Effective Bridging Therapy Can Improve CD19 CAR T-Cell Therapy Outcomes While Maintaining Safety in Patients With LBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma
Blood Adv 2023 Feb 01;[EPub Ahead of Print], C Roddie, L Neill, W Osborne, S Iyengar, E Tholouli, D Irvine, S Chaganti, C Besley, AJ Bloor, CH Jones, BJ Uttenthal, RJ Johnson, R Sanderson, KP Cheok, MAV Marzolini, WM Townsend, M O'Reilly, AA Kirkwood, A KuhnlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.